- Home
- COE vs FDMT Comparison
COE vs FDMT Comparison
Compare COE & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- FDMT
- Stock Information
- Founded
- COE 2011
- FDMT 2013
- Country
- COE Singapore
- FDMT United States
- Employees
- COE N/A
- FDMT N/A
- Industry
- COE Other Consumer Services
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- COE Real Estate
- FDMT Health Care
- Exchange
- COE Nasdaq
- FDMT Nasdaq
- Market Cap
- COE 177.0M
- FDMT 192.2M
- IPO Year
- COE 2016
- FDMT 2020
- Fundamental
- Price
- COE $30.40
- FDMT $6.42
- Analyst Decision
- COE
- FDMT Buy
- Analyst Count
- COE 0
- FDMT 9
- Target Price
- COE N/A
- FDMT $31.38
- AVG Volume (30 Days)
- COE 11.3K
- FDMT 1.9M
- Earning Date
- COE 08-22-2025
- FDMT 08-15-2025
- Dividend Yield
- COE N/A
- FDMT N/A
- EPS Growth
- COE N/A
- FDMT N/A
- EPS
- COE N/A
- FDMT N/A
- Revenue
- COE $59,490,000.00
- FDMT $23,000.00
- Revenue This Year
- COE N/A
- FDMT $11,586.49
- Revenue Next Year
- COE N/A
- FDMT N/A
- P/E Ratio
- COE N/A
- FDMT N/A
- Revenue Growth
- COE 91.87
- FDMT N/A
- 52 Week Low
- COE $11.84
- FDMT $2.24
- 52 Week High
- COE $34.74
- FDMT $18.02
- Technical
- Relative Strength Index (RSI)
- COE 59.96
- FDMT 78.11
- Support Level
- COE $28.50
- FDMT $4.30
- Resistance Level
- COE $29.38
- FDMT $4.75
- Average True Range (ATR)
- COE 1.01
- FDMT 0.37
- MACD
- COE -0.13
- FDMT 0.11
- Stochastic Oscillator
- COE 42.83
- FDMT 89.53
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.